SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
______________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report: August 24, 2000
(Date of earliest event reported)
MEDISYS TECHNOLOGIES, INC.
(Exact name of Registrant as specified in charter)
Utah 0-21441 72-1216734
(State or other juris- (Commission (IRS Employer
diction of incorporation) File No.) Identification No.)
144 Napoleon Street, Baton Rouge, Louisiana 70802
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone no., including area code: (225) 343-8022
N/A
(Former Name or Former Address, if Changed Since Last Report)
Item 5. Other Events.
On August 24, 2000, a Magistrate for the United States
District Court, Middle District of Florida, in the action brought
by Plaintiffs Carl Anderson, William Morris and Brett Phillips
against various director of Medisys Technologies, Inc., issued a 39
page Report and Recommendation to the Federal District Court Judge.
The Report followed an Evidentiary Hearing held before the
Magistrate on Plaintiffs' Motion for Preliminary Injunction,
Defendants' Motion to Dismiss the Derivative Claims and Defendants'
Motion to Dismiss Plaintiff Anderson's Individual claim. The Report
recommended that the Federal District Court Judge deny Plaintiffs'
Motion for Preliminary Injunction and grant Defendants' Motion to
Dismiss the Derivative Claims and further dismiss Plaintiff
Anderson's Individual Claim. All parties were then permitted to
file written responses with the Court before the Report and
Recommendation was submitted to the Federal District Judge for
final ruling. The parties now await the Federal District Court
Judge's final ruling on the Magistrate's recommendations to
dismiss.
On October 11, 2000, the United States District Court for the
District of Utah, Central Division, in the litigation brought by
Medisys Technologies, Inc. against various defendants, including
Carl Anderson, William Morris and Brett Phillips, concluded a two
day Evidentiary Hearing on Plaintiff's Motion for Preliminary
Injunction which sought an Order restraining the Defendants from
trading shares acquired as a result of the acquisition of Phillips
Pharmatech Labs from the Defendants. At the conclusion of the
hearing, the Judge denied Plaintiff's motion for preliminary
injunctive relief. The Court will hear additional Motions in this
matter as the case proceeds to a trial on the merits of the claim.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
MEDISYS TECHNOLOGIES, INC.
Dated: October 23, 2000 By: /S/ Kerry M. Frey
KERRY M. FREY,
President and Chief Operating Officer
